BLFS: BioLife Growth-Adjusted Market Cap to Net Income
This PEG chart from the GURU.Markets precision service allows for an assessment of the growth potential of BioLife Solutions, Inc. (BLFS), where the value 0.00 indicates the current metric. BioLife Solutions, Inc. (BLFS) operates high-tech plants in the US, ensuring stable supplies of cryopreservation media. The company's environmental development vector involves the implementation of reusable packaging, while steady demand for consumables guarantees a regular cash flow.
Metric breakdowns and analytics for BioLife Solutions, Inc. (BLFS)
- current price and projected stock value:
- market capitalization information:
- company book value details:
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio BioLife Solutions, Inc.|BLFS - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient biolifesolutions.com|BLFS - Company Debts|Debts to Book Value BioLife Corp|BLFS - Company Long-Term Debt|Company Short-Term Debt BioLife Solutions|Quick Ratio biolifesolutions.com
- earnings and valuation multiples indicators:
BLFS - Net Income|Future Net Profit BioLife Solutions, Inc.|BLFS - P/E Multiple|Market Cap to Projected Earnings BioLife|BLFS - Price/Earnings to Growth Ratio|Company Value to EBITDA BioLife Corp|BLFS - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months BioLife Solutions|BLFS - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months biolifesolutions.com|BLFS - Net earnings per share growth this year|Expected earnings per share trend next year BioLife Solutions, Inc.
Fundamental company analysis:BLFS - BioLife Solutions Inc
The pricing power of BioLife Solutions, Inc. (BLFS), rooted in the integration of its consumables into the technical processes of pharma behemoths, creates sustainable potential for profit scaling. Comparing the P/E multiple with these growth rates allows for the identification of fundamental asset undervaluation via the growth-adjusted P/E ratio when figures fall below one, distinguishing the real potential of a "rocket" from the risks of capital stagnation.
Competitors of BioLife Solutions, Inc.
Price/Earnings to Growth Ratio TEM (Tempus AI, Inc)|PEG Multiple QGEN (Qiagen Group)|Growth-Adjusted Market Cap to Net Income Isis Pharmaceuticals (IONS)|Repligen Corporation - PEG Multiple|Market Cap to Earnings and Growth Ratio RNA|CRSP: PEG Multiple|Price to Earnings Adjusted for Growth Rate GeneDx Holdings (WGS)|Price/Earnings to Growth Multiple RARE|BEAM: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Sarepta Therapeutics, Inc. (SRPT)|Growth-Adjusted Market Cap to Net Income twistbioscience.com|Price/Earnings to Growth Ratio 10x Genomics TXG|Intellia Therapeutics Inc (NTLA) - Price to Earnings Adjusted for Growth Rate|STOK - Price/Earnings to Growth Ratio|WVE: Price/Earnings to Growth Ratio|MAZE (Maze Therapeutics Inc) - Price/Earnings to Growth Multiple|sionnatx.com (SION) - PEG Multiple|Price/Earnings to Growth Multiple PRME|TSHA (Taysha Gene Therapies Inc) - Company Value to Earnings Growth Ratio|PEG Multiple QURE|Growth-Adjusted Market Cap to Net Income MeiraGTx Corp|Price/Earnings to Growth Ratio REGENXBIO Inc. RGNX|solidbio.com (SLDB) - Price to Earnings Adjusted for Growth Rate|OCGN - Price/Earnings to Growth Ratio|PACB (Pacific Biosciences of California, Inc.) - Growth-Adjusted P/E Ratio|Benitec (BNTC) - Price/Earnings to Growth Ratio|DSGN - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple RCKT|FDMT: Growth-Adjusted Payback Ratio|PEG Multiple LXEO|Growth-Adjusted Market Cap to Net Income korrobio.com|Price/Earnings to Growth Ratio Editas EDIT|SLN: Growth-Adjusted P/E Ratio|ProQR Therapeutics NV - PEG Multiple|Codexis, Inc. (CDXS) - Price/Earnings to Growth Multiple|SGMO (Sangamo Therapeutics, Inc.) - Price/Earnings to Growth Multiple|NAUT - Growth-Adjusted Market Cap to Net Income|MGX (Metagenomi, Inc) - PEG Multiple|Price/Earnings to Growth Ratio DTIL|Price/Earnings to Growth Ratio Generation Bio Co. (GBIO)|Price/Earnings to Growth Ratio BOLD (boundlessbio.com)|PEG Multiple XCUR (Exicure)|IMNN (Imunon Inc) - Market Cap to Earnings and Growth Ratio|PHIO - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Mustang Bio, Inc. MBIO|RNAZ: PEG Multiple|Growth-Adjusted P/E Ratio BNGO|Price/Earnings to Growth Ratio Applied DNA Sciences, Inc.|Growth-Adjusted P/E Ratio BLUE (bluebird bio Inc.)|PEG Multiple IPA|PEG Multiple Omega Therapeutics Corp (OMGA)|PEG Multiple OMIC (Singular Genomics Systems)|regulusrx.com - Price/Earnings to Growth Ratio|Syros Pharmaceuticals, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Telesis Bio Inc. TBIO|TRACON (TCON) - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate Unity Biotechnology, Inc (UBX)
